| Role |
Name |
Disclosure |
Details |
| Author | Mark R Allee, MD, Assistant Professor, Department of Medicine, University of Oklahoma Health Sciences Center | Nothing to disclose | Details | | Coauthor | Mary Zoe Baker, MD, Professor, Department of Medicine, Section of Endocrinology, Metabolism and Hypertension, University of Oklahoma; Medical Director, University of Oklahoma Physicians, Medicine Specialty Clinic, General Medicine Clinic and Medicine Residents' Clinic | Nothing to disclose | Details | | Medical Editor | Barry J Goldstein, MD, PhD, Director, Division of Endocrinology, Diabetes and Metabolic Diseases, Department of Internal Medicine, Professor, Thomas Jefferson University | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Yoram Shenker, MD, Chief of Endocrinology Section, VA Hospital of Madison, Section of Endocrinology, Diabetes and Metabolism, Interim Chief, Associate Professor, Department of Internal Medicine, University of Wisconsin at Madison | Nothing to disclose | Details | | CME Editor | Mark Cooper, MD, Head, Vascular Division, Baker Medical Research Institute; Professor of Medicine, Monash University | Nothing to disclose | Details | | Chief Editor | George T Griffing, MD, Professor of Medicine, Director of General Internal Medicine, St Louis University | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Mary Zoe Baker, Coauthor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Yoram Shenker, Managing Editor |
The contributor discloses no conflict of interest. |
|